Poland· PL-100253146
Megastril
A megestrol product containing megestroli acetas, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Megestrol is registered in 11 of 19 countries.
Countries holding a registration under ATC L02AB01 (megestrol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Megestrol · ATC L02AB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of megestrol costs, country by country.
Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Megestrol · price per daily dose (0.16 g)
USD · FX 28 Sept 2026
- IT Italy$2.30
The record
At a glance
URPL (Poland)- Active substance
- Megestroli acetas
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- L02AB01
- ATC class
- Megestrol
- Defined daily dose
- 0.16 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- gtin05909990895977240 mlPLN 139.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
152 interactions on record for megestrol.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Megestrol · interactions on record
152 records
- 2 severe
- 147 moderate
- 3 minor
Most severe, free to view
- DofetilideC01BD04severe
- ThalidomideL04AX02severe
- AprepitantA04AD12moderate
- LiraglutidA08AX02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Megestrol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMegestrol AcetatePAI Holdings, LLC dba PAI Pharma
- IrelandMegace 40 mg/ml oral suspensionPCO Manufacturing Ltd.
- SpainMAYGACE ALTAS DOSIS 40 mg/ml SUSPENSION ORALBausch Health Ireland Limited
- CzechiaMEGACEBausch Health Ireland Limited, Dublin
- United KingdomMegace 160mg tabletsWaymade Healthcare Plc
- ItalyGESTROLTEXISTITUTO GENTILI S.R.L.
- FinlandMegaceBristol-Myers Squibb Ab
- CanadaMEGESTROLAA PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Megace
- Cyprus · Megace
- Czechia · Megace, Megaplex
- Germany · Megestat
- Spain · Borea, Maygace Altas Dosis
- France · Megace
- United Kingdom (Northern Ireland) · Megace
- Greece · Megace
- Croatia · Megace, Megostat
- Hungary · Cachexi, Megace
- Ireland · Megace
- Italy · Gestroltex, Megace
- Lithuania · Megace
- Luxembourg · Megace
- Netherlands · Megestrolacetaat Focus
- Norway · Megace
- Portugal · Megace, Megestrol Generis
- Romania · Megesin
- Sweden · Megace
- Slovenia · Megace
- Slovakia · Megesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1850e192-1a21-4679-88c2-9de2a41afda8 GET /v1/drugs/1850e192-1a21-4679-88c2-9de2a41afda8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina doustna",
"source": "urpl",
"strength": "40 mg/ml",
"packaging": "05909990895977 ¦ Rp ¦ 68796\n1 butelka 240 ml",
"substance": "Megestroli acetas 40 mg/ml",
"common_name": "Megestroli acetas",
"pl_product_id": "100253146",
"pozwolenie_nr": "18584",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about megestrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.